Clinical Trial Update: Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating orexin receptor antagonism to improve sleep in people with stimulant use disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stimulant Use Disorder

Drugs mentioned

• Orexin receptor antagonist

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Stimulant Use Disorder | Phase 2 | Status: RECRUITING